Mumbai/ Ahmedabad: Ahmedabad based Lincoln Pharmaceuticals Ltd. (LPL), has tied up with US based Human Biosciences Inc (HBI) for exclusive marketing and distribution of two of HBI's wound care management products in India, Medifil and Skin Temp that enjoy a 22 per cent market share in its category in India. The company can set up a manufacturing unit in the future to increase production of these products.
Speaking on the development, Mahendra G Patel, managing director, Lincoln Pharmaceutical Ltd. said, “Our mission at Lincoln Pharmaceuticals is to provide customers with healthcare products of high quality at an affordable price. We are planning to set up a manufacturing unit in India to increase production and expand our reach so that more people can avail the benefits of these products.”
Collagen products have reconstructive properties and are meant for wound care management.
Medifil and Skin Temp, considered a helps to stop the bleeding immediately by providing faster and better wound healing.
In addition, it has better aesthetic value as it heals without leaving any scar formation. Medifil and Skin Temp are specifically useful in repairing wounds during plastic and burns surgery, general surgery, orthopedic surgery and gynecological surgery and is particularly beneficial for diabetic amputations due to its faster healing properties. Medifil is available in an absorbable Collagen based granule and Skin Temp in an absorbable Collagen based patch.
Lincoln Pharmaceuticals is into manufacturing and marketing therapeutic products under WHO-GMP guidelines.
No comments:
Post a Comment